What are the current treatment options for a person with diabetic retinopathy ?
Because the earliest stages of diabetic retinopathy include inflammation, intraocular corticosteroids have been utilized with some success in selected patients. This form of treatment includes the use of a long-acting corticosteroid (triamcinolone acetonide) injected into the vitreous cavity by way of a very tiny needle under topical (drops) anesthesia. This treatment may reduce retinal swelling and improve visual acuity in patients with diabetic macular edema. However, visual recovery may be limited and the effect may last only 3 to 6 months after the treatment. Other newer modalities like Anti vascular endothelial growth factor drugs( Lucentis, Macugen and Avastin )have been proved to be quite successful in reducing macular edema and new vessels temporarily. However they do not work well all alone unless combined with adequate photocoagulation.
What does Shree Ramkrishna Netralaya offer patients with diabetic retinopathy?
Diabetic Eye Unit established at SRN provides constant care for diabetic patients. It involves routine screening of diabetics to detect retinopathy. If detected early patients can be managed medically by FFA and laser treatment, thereby preventing further decrease in vision. We have found very encouraging results with use of Anti VEGF drugs like Avastin and Lucentis in cases of macular oedema and PDR cases .
Patients presenting at a later stage with decreased vision due to vitreous hemorrhage and tractional retinal detachment require vitrectomy We have experienced VR surgeon to perform vitreoretinal sugeries
Procedures at Shree Ramkrishna Netralaya
PRP( Pan retinal photocoagulation) argon Green laser (Iris Medical, USA)
A R M D Management
PDT (Photo Dynamic Therapy)
Anti VEGF Injections (Lucentis and Macugen
Fundus fluorescein angiography (FFA) with Fundus Camera (Carl Zeiss Meditech, Germany)